Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan—The KBCOG-14 Study

BACKGROUND: Clinical studies have shown that palbociclib improves progression-free survival in hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2−) patients with advanced breast cancer (ABC). However, there are insufficient data on its use in a real-world settin...

Descripción completa

Detalles Bibliográficos
Autores principales: Odan, Nina, Kikawa, Yuichiro, Matsumoto, Hajime, Minohata, Junya, Suwa, Hirofumi, Hashimoto, Takashi, Okuno, Toshitaka, Miyashita, Masaru, Saito, Masaru, Yamagami, Kazuhiko, Takao, Shintaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780165/
https://www.ncbi.nlm.nih.gov/pubmed/33447040
http://dx.doi.org/10.1177/1178223420983843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780165/
https://www.ncbi.nlm.nih.gov/pubmed/33447040
http://dx.doi.org/10.1177/1178223420983843

Ejemplares similares